Key Developments
Major institutes and universities are focused on R&D activities related to candidiasis. For instance, on September 09, 2019, a team of researchers from Southmead Hospital, Bristol, in collaboration with Triticum Exploitatie B.V., tested the vulnerability of Candida albicans to honey and an MGH formulation (L-Mesitran) by evaluating five isolates from vaginal samples of symptomatic patients suffering from recurrent vulvovaginal candidiasis.
In August 2019, researchers from Complutense University of Madrid developed fast-dissolving orodispersible films of amphotericin B for oropharyngeal candidiasis.
In July 2019, researchers from Instituto de Química Rosario, Argentina, designed chitosan nanoformulations for the delivery of antifungal agents. The approach can aid in the development of a pharmaceutical dosage form suitable for the treatment of vaginal candidiasis.
Candidiasis Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients